ReCAP is a series of interviews with the members of the RBDCOV Community Advisory Panel that will explore the world of community engagement, EU projects and the importance of including people living with immunocompromising conditions in clinical trials.   Today, we bring you the third and last part of this interesting conversation with Siegfried Schwarze, … Continue reading RECAP with the RBDCOV Community Advisory Panel | Vaccines 101: The importance of including people living with immunocompromising conditions